Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 per month
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 583, S12-S14 (2020)
doi: https://doi.org/10.1038/d41586-020-02111-z
This article is part of Nature Outlook: Cystic fibrosis, an editorially independent supplement produced with the financial support of third parties. About this content.
Updates & Corrections
-
Correction 27 August 2020: An earlier version of this Outlook article used the wrong pronoun when referring to Sriram Vaidyanathan.
References
Middleton, P. G. et al. N. Engl. J. Med. 381, 1809–1819 (2019).
Rommens, J. M. et al. Science 245, 1059–1065 (1989).
Drumm, M. L. et al. Cell 62, 1227–1233 (1990).
Rich, D. P. et al. Nature 347, 358–363 (1990).
Zabner, J. et al. Cell 75, 207–216 (1993).
Wagner, J. A. et al. Laryngoscope 109, 266–274 (1999).
Alton, E. W. F. W. et al. Lancet Respir. Med. 3, 684–691 (2015).
Maule, G. et al. Nature Commun. 10, 3556 (2019).
Geurts, M. H. et al. Cell Stem Cell 26, 503–510 (2020).
Vaidyanathan, S. et al. Cell Stem Cell 26, 161–171 (2020).
Cystic fibrosis drugs target the malformed proteins at the root of the disease
A simple test could extend cystic-fibrosis treatments to those left behind
In utero intervention to stem the damage of cystic fibrosis
Bacteria-eating viruses could provide a route to stability in cystic fibrosis
The gender gap in cystic fibrosis
The coronavirus pandemic has forced rapid changes in care protocols for cystic fibrosis
Living, breathing proof
How much protein function needs to be restored in cystic fibrosis?
Research round-up: Cystic fibrosis
